Panacea Biotec Limited has informed the Exchange regarding 'Receipt of Approval for Reclassification of Mrs. Sunanda Jain, Mr. Sumit Jain and Ms. RadhikaJain from Promoters & Promoters Group category to Public category of PanaceaBiotec Limited'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has received approval from BSE and NSE to reclassify Mrs. Sunanda Jain, Mr. Sumit Jain, and Ms. Radhika Jain from the Promoters and Promoters' Group category to the Public category under SEBI's Regulation 31A. The original application was filed on October 16, 2024, and approval was granted on July 29, 2025. Importantly, all three individuals hold zero shares in the company, so the promoter group shareholding remains unchanged at 72.48% (4,43,94,190 shares), and public holding stays at 27.52% (1,68,56,556 shares). This is essentially a procedural reclassification with no impact on the company's ownership structure or shareholding percentages.
No material impact on shareholders — this is a housekeeping reclassification since the three individuals hold no shares. Promoter group control and public holding percentages remain exactly the same, so there should be no effect on the stock price or shareholder dynamics.